NG
IONS icon

Norden Group’s Ionis Pharmaceuticals IONS Stock Holding History

Norden Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$213K Sell
2,685
-204
-7% -$15.4K 0.02% 649
2026
Q1 		$217K Sell
2,889
-46
-2% -$3.63K 0.02% 572
2025
Q4 		$232K Buy
+2,935
New +$221K 0.02% 547

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Norden Group's IONS Position: Q2 2026 in Review

Norden Group reduced its Ionis Pharmaceuticals (IONS) stake by 7.1% in Q2 2026, selling an estimated $15.4K and leaving 2,685 shares worth $213K. The position accounts for 0.02% of the portfolio, ranked #649.

Norden Group first reported a position in IONS in Q4 2025 and has held it in 3 quarters since. The position peaked at $232K in Q4 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Norden Group held 2,685 shares of Ionis Pharmaceuticals worth $213K as of Q2 2026.
  • Norden Group sold 204 Ionis Pharmaceuticals shares in Q2 2026, an estimated $15.4K.
  • Ionis Pharmaceuticals made up 0.02% of Norden Group's portfolio in Q2 2026, its #649 holding.
  • Norden Group first reported a position in Ionis Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Norden Group's Ionis Pharmaceuticals position peaked at $232K in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.